Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 6Rhabdomyosarcoma 5Sarcoma, Synovial 3Osteosarcoma 3Sarcoma, Ewing 2Neuroectodermal Tumors, Primitive, Peripheral 2Liposarcoma 2Leiomyosarcoma 2Hemangiosarcoma 2Fibrosarcoma 2Wilms Tumor 1Retinoblastoma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive 1Neuroectodermal Tumors 1Neuroblastoma 1Malignant mesenchymal tumor 1Histiocytoma, Malignant Fibrous 1Hepatoblastoma 1Hemangiopericytoma, Malignant 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Adrenocortical Carcinoma 1

Interventions

Ifosfamide 8Doxorubicin 8Radiotherapy 6Chemotherapy, Adjuvant 4Neoadjuvant Therapy 3Filgrastim 3Vincristine 2Trabectedin 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2vatalanib 1soblidotin 1romidepsin 1perifosine 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1Watchful Waiting 1Temozolomide 1Sunitinib 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiopericytoma, Malignant × cixutumumab × Sarcoma × Clear all
NCT00720174 2016-05-17

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡